The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...
The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...
Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.
Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal ...
A U.S. robotics company has developed Jennie, a robotic pet powered by artificial intelligence that's designed to comfort those facing mental health challenges.
The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.
Reaching for a diet soda or artificially sweetened snack to lose weight or to enjoy a few more treats? A growing number of scientists believe that’s not a good idea.
Feeling Blue? Holiday Lights Might Be the CureMental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just looking at twinkling ...
Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...
The choice to try a drug is a decision that that is centered in the executive portion of the brain, the prefrontal cortex. Once consumed, the drug delivers a powerful stimulus to the nucleus ...